In this issue of Blood, Miraki-Moud et al demonstrate that the majority of acute myeloid leukemias (AMLs) have low expression of argininosuccinate synthetase-1 (ASS1), rendering AML cell lines and primary AML blasts dependent on exogenous arginine and sensitized to arginine deprivation.

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-05-643411DOI Listing

Publication Analysis

Top Keywords

arginine addiction
4
addiction aml
4
aml issue
4
issue blood
4
blood miraki-moud
4
miraki-moud demonstrate
4
demonstrate majority
4
majority acute
4
acute myeloid
4
myeloid leukemias
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!